Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Valneva's stock is up 3.02% this Wednesday, November 12, in mid-session, trading at 3.9580 euros. The share of the Franco-Austrian biotech specializin…
Valneva closed the trading session on Tuesday, November 11, 2025, at 3.84 euros, marking a 3.28% increase from the previous day. The vaccine specialis…
Valneva's stock experienced a sharp correction during the last five trading sessions, in a market environment generally trending downward. Benchmark i…
Valneva SE has reported positive Phase 1 results for its VLA1601 Zika virus vaccine candidate, indicating an enhanced immune response with double adju…
After a strong performance on Tuesday due to positive news about its Zika virus vaccine candidate, VALNEVA has declined at the end of Wednesday, Novem…
Valneva has disclosed positive outcomes from the first phase of clinical trials for its second-generation vaccine candidate against the Zika virus.
The vaccine laboratory's stock significantly rebounds this Wednesday, moving from €3.90 to €4.03 by late morning. This movement marks a welcome revers…
VALNEVA shares lose ground on Monday midday, trading at €3.98, showing a decline of 2.07% from Friday's close. This downturn is part of a more concern…
Valneva has announced that its management will participate in presentations and individual meetings with institutional investors at upcoming conferenc…
Over the past week, Valneva's stock experienced a significant correction, dropping 8.67% to close at 4.06 euros on Thursday, October 24. This decline …
